BU Mass Spec Resource to Collaborate With Bruker | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker Daltonics and Boston University's Mass Spectrometry Resource plan to collaborate to apply high performance ion trap mass spectrometry and Fourier transform mass spec to glycomics and proteomics research, Bruker announced today.

Catherine Costello, director of the Boston University School of Medicine's Center for Biomedical Mass Spectrometry, and her colleagues plan to use Bruker's solariX FTMS with a 12 Tesla magnet, with electron transfer dissociation and electron capture dissociation capabilities, for their proteomics and glycomics studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.